C

Cellectis SA
D

CLLS

1.48000
USD
-0.05
(-3.27%)
مغلق
حجم التداول
538
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
148,429,526
أصول ذات صلة
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
B
BLUE
0.00500
(0.10%)
4.99000 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
C
CLDX
-0.010
(-0.05%)
20.375 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
J
JAZZ
0.360
(0.33%)
108.120 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
المزيد
الأخبار المقالات

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.